Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea.
Ahn SY, Son SK, Lee GH, Kim I, Cheong JW, Lee WS, Kim BS, Jo DY, Jung CW, Seong CM, Lee JH, Yuh YJ, Kim MK, Ryoo HM, Park MR, Cho SH, Kim HG, Zang DY, Park J, Kim H, Lee S, Kim SH, Chang MH, Lee HS, Choi CW, Kwon J, Lim SN, Oh SJ, Joo I, Kim DW.
Ahn SY, et al. Among authors: seong cm.
Blood Res. 2022 Jun 30;57(2):144-151. doi: 10.5045/br.2022.2021137. Epub 2022 Jun 10.
Blood Res. 2022.
PMID: 35678158
Free PMC article.